Global trial fast tracks testing of hydroxychloroquine, other COVID-19 therapies
Thursday, 9 April 2020 A novel 'learning while doing' clinical trial approach called REMAP helps doctors find the optimal trade-off between quickly adopting new therapies during a pandemic, such as the anti-malarial drug hydroxychloroquine, and waiting until they are tested in longer clinical trials. The trial learns from similar trials enrolling around the world and uses artificial intelligence to quickly arrive at answers.
The World Health Organization is pausing clinical trials of hydroxychloroquine as a possible treatment for the novel coronavirus COVID-19. According to Business Insider, the WHO's steering committee of..